Shareholder Alert: Ademi LLP investigates whether Augmedix, Inc. has obtained a Fair Price for its Public Shareholders
- MILWAUKEE , July 19, 2024 /PRNewswire/ -- Ademi LLP is investigating Augmedix (Nasdaq: AUGX) for possible breaches of fiduciary duty and other violations of law in its transaction with Commure. Click here to learn how to join our investigation https://www.ademilaw.com/case/augmedix-inc or call Guri Ademi toll-free at 866-264-3995.
- 07/19/2024
|
Augmedix to Join Forces with Commure
- Combination to Strengthen Ability to Deliver Frontier Ambient AI Solutions; Augmedix Stockholders to Receive $2.35 Per Share in All-Cash Acquisition by Commure Combination to Strengthen Ability to Deliver Frontier Ambient AI Solutions; Augmedix Stockholders to Receive $2.35 Per Share in All-Cash Acquisition by Commure
- 07/19/2024
|
Emergency Services Inc. Partners with Augmedix to Introduce Generative AI Solution That Relieves Clinician Burnout in Emergency Departments
- Emergency Services Inc. introduces Augmedix Go ED to central Ohio emergency departments to automate medical documentation Emergency Services Inc. introduces Augmedix Go ED to central Ohio emergency departments to automate medical documentation
- 06/20/2024
|
Augmedix Reiterates Second Quarter and Full Year 2024 Outlook
- Management Provides Update in Advance of William Blair Annual Growth Stock Conference Appearance Management Provides Update in Advance of William Blair Annual Growth Stock Conference Appearance
- 06/04/2024
|
Augmedix Appoints Alex Stinard, M.D., as Chief Clinical AI Officer
- Unique combination of clinical experience and AI technological expertise will aid Augmedix in solving clinicians' challenges with advanced ambient medical documentation solutions Unique combination of clinical experience and AI technological expertise will aid Augmedix in solving clinicians' challenges with advanced ambient medical documentation solutions
- 05/29/2024
|
Why Is Augmedix (AUGX) Stock Down 41% Today?
- Augmedix (NASDAQ: AUGX ) stock is sliding lower on Tuesday after the medical documentation solutions company released its Q1 2024 earnings report. The bad news for AUGX investors comes from its outlook update.
- 05/14/2024
|
Augmedix, Inc. (AUGX) Q1 2024 Earnings Call Transcript
- Augmedix, Inc. (NASDAQ:AUGX ) Q1 2024 Earnings Conference Call May 13, 2024 4:30 PM ET Company Participants Matt Chesler - IR Manny Krakaris - CEO Paul Ginocchio - CFO Conference Call Participants Ryan Daniels - William Blair Elizabeth Anderson - Evercore ISI Aaron Wukmir - Lake Street Capital Markets Yuan Zhi - B. Riley Securities Allen Klee - Maxim Group Bill Sutherland - The Benchmark Company Operator Ladies and gentlemen, greetings and welcome to the Augmedix, Inc. First Quarter 2024 Earnings Conference Call.
- 05/13/2024
|
Augmedix Delivers 40% Revenue Growth for First Quarter of 2024
- SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended March 31, 2024.
- 05/13/2024
|
Augmedix to Participate in Upcoming Investor Conferences in May and June 2024
- SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced that its management team will participate in the following four investor conferences in May and June 2024.
- 05/03/2024
|
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments
- Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departments Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departments
- 04/24/2024
|
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
- Let's just get something straight off the bat – penny stocks to rebound are risky. They're incredibly treacherous in terms of both short-term downside and longer-term damage to your portfolio.
- 04/19/2024
|
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
- SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and allow clinicians to focus on patient care, Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today that it has integrated with Andor Health , an AI-first cloud-based communication and collaboration platform for virtual care.
- 04/09/2024
|
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
- The partnership enables Augmedix to accelerate scaling efforts for digital health solutions and integrations that work seamlessly at the point of care The partnership enables Augmedix to accelerate scaling efforts for digital health solutions and integrations that work seamlessly at the point of care
- 04/04/2024
|
Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward
- Augmedix is a company developing an AI-driven medical documentation platform for hospitals and physicians. The company's stock performance has been underwhelming since going public, with a current all-time return of -15%. The company's financials show steady growth but continued losses, and there are concerns about profitability and cash flow generation, making risk-reward unattractive for now.
- 03/24/2024
|
Augmedix, Inc. (AUGX) Q4 2023 Earnings Call Transcript
- Augmedix, Inc. (AUGX) Q4 2023 Earnings Call Transcript
- 03/18/2024
|
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
- SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three and 12 months ended December 31, 2023.
- 03/18/2024
|
Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go
- New Data Shows Clinicians Save Up to 1 Hour or More per Day Using Augmedix Go New Data Shows Clinicians Save Up to 1 Hour or More per Day Using Augmedix Go
- 03/12/2024
|
Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
- SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will release fourth quarter and full year 2023 results after the market closes on Monday, March 18, 2024. Following the release, management will host a conference call and audio webcast to review results and provide a brief business and outlook update that same day at 1:30 p.m. PT / 4:30 p.m. ET.
- 03/08/2024
|
Augmedix to Participate in Citizens JMP Technology Conference
- SAN FRANCISCO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that members of its management team will participate in a fireside chat and host investor meetings at the Citizens JMP Technology Conference taking place in San Francisco on March 4, 2024.
- 02/27/2024
|
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Augmedix, Inc. (NASDAQ: AUGX)
- NEW YORK , Feb. 22, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Augmedix, Inc. (NASDAQ: AUGX) on behalf of the company's shareholders. The investigation seeks to determine whether Augmedix's directors breached their fiduciary duties in connection with recent corporate actions.
- 02/22/2024
|
Augmedix Names Tomer Levy as New Senior Vice President of Engineering
- With deep experience in developing operational efficiency and innovation, Levy will be working to aid Augmedix in scaling its products, accelerating product development, and aligning with the needs of large healthcare enterprises With deep experience in developing operational efficiency and innovation, Levy will be working to aid Augmedix in scaling its products, accelerating product development, and aligning with the needs of large healthcare enterprises
- 02/13/2024
|
Augmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor Conference
- SAN FRANCISCO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that it will participate in the Maxim Group Virtual Healthcare IT Conference on January 24, 2024. Manny Krakaris, Chief Executive Officer, will join a fireside chat with Allen Klee, Equity Research Analyst.
- 01/16/2024
|
Augmedix is an ambient AI healthcare optimization play
- Augmedix Inc. NASDAQ: AUGX is an artificial intelligence (AI) powered ambient medical documentation solutions provider in the medical sector. It utilizes generative AI for documenting medical records and transcribing medical notes and conversations, which are seamlessly integrated into the electronic health record (EHR) system used by healthcare systems, insurers, offices, and practices.
- 01/09/2024
|
Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
- Company Also Expects Fourth Quarter 2023 Revenue Above Guidance, Announces General Availability of Augmedix Go Company Also Expects Fourth Quarter 2023 Revenue Above Guidance, Announces General Availability of Augmedix Go
- 01/05/2024
|
Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- The general availability launch of MedLM will further advance Augmedix's ambient medical documentation product performance SAN FRANCISCO , Dec. 13, 2023 /PRNewswire/ -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today that it has been piloting Google Cloud's Med-PaLM 2 and will integrate Google Cloud's newly introduced MedLM technology into its technology stack. This model suite uses the latest AI developments adapted for healthcare use cases and meets Augmedix's stringent requirements around AI safety, compliance, and enterprise scalability.
- 12/13/2023
|
Buy Augmedix After $25 Million Equity Funding Round
- Augmedix dropped in price by 20%+ after announcing a 5.5 million share offering of common stock that was later upsized to 6.25 million shares. Despite concerns of dilution, I rate AUGX a Buy for its revenue growth undergirded by a promising future in the AI marketplace. The Company's product eliminates data entry tasks for doctors, allowing them to focus on delivering care to patients.
- 11/20/2023
|
How Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67%
- The consensus price target hints at a 36.7% upside potential for Augmedix, Inc. (AUGX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- 11/10/2023
|
Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable
- Augmedix, Inc. (AUGX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
- 11/10/2023
|
Augmedix, Inc. (AUGX) Q3 2023 Earnings Call Transcript
- Augmedix, Inc. (AUGX) Q3 2023 Earnings Call Transcript
- 11/06/2023
|
Augmedix to Announce Third Quarter 2023 Financial Results and Host Investor Conference Call on November 6, 2023
- SAN FRANCISCO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will report financial results for the third quarter ended September 30, 2023, on Monday, November 6, 2023, after the market closes. Management will host a conference call that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
- 10/30/2023
|
Augmedix, Inc. (AUGX) Soars 7.6%: Is Further Upside Left in the Stock?
- Augmedix, Inc. (AUGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 10/12/2023
|
Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable
- If you are looking for stocks that are well positioned to maintain their recent uptrend, Augmedix, Inc. (AUGX) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
- 10/09/2023
|
Augmedix: Using AI To Make Healthcare More Efficient
- Augmedix offers AI-based solutions for the healthcare industry, allowing clinicians to spend more time on patient care. The company's solutions include remote medical documentation services and live clinical support services. Augmedix's above-average revenue growth makes it a promising stock with potential for long-term out-performance.
- 10/03/2023
|
3 Best Breakout Stocks to Buy Now for Solid Returns
- Lifeway Foods (LWAY), Augmedix (AUGX) and Clearwater Analytics Holdings (CWAN) have been selected as the breakout stocks for today.
- 09/22/2023
|
Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable
- Augmedix, Inc. (AUGX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
- 09/21/2023
|
Are Medical Stocks Lagging Augmedix (AUGX) This Year?
- Here is how Augmedix, Inc. (AUGX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.
- 09/12/2023
|
Recent Price Trend in Augmedix, Inc. (AUGX) is Your Friend, Here's Why
- Augmedix, Inc. (AUGX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
- 09/05/2023
|
Can Augmedix, Inc. (AUGX) Climb 36.06% to Reach the Level Wall Street Analysts Expect?
- The average of price targets set by Wall Street analysts indicates a potential upside of 36.1% in Augmedix, Inc. (AUGX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- 09/04/2023
|
Augmedix Announces Participation in Upcoming Investor Conferences in September 2023
- SAN FRANCISCO, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced that it will participate in the following investor conferences during September 2023.
- 08/18/2023
|
Augmedix, Inc. (AUGX) Is a Great Choice for 'Trend' Investors, Here's Why
- Augmedix, Inc. (AUGX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
- 08/16/2023
|
Why Shares of Augmedix Are Climbing on Tuesday
- Augmedix offers software platforms for medical documentation designed to save physicians time. The company saw revenue climb by 47% year over year in the second quarter.
- 08/08/2023
|
Augmedix, Inc. (AUGX) Q2 2023 Earnings Call Transcript
- Augmedix, Inc. (NASDAQ:AUGX ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Matt Chesler - IR Manny Krakaris - CEO Paul Ginocchio - CFO Conference Call Participants Jared Haasec - William Blair Neil Chatterji - B. Riley Securities Aaron Wukmir - Lake Street Capital Markets Allen Klee - Maxim Group LLC Operator Ladies and gentlemen, greetings, and welcome to the Augmedix Inc. Second Quarter 2023 Earnings Conference Call.
- 08/07/2023
|
Augmedix, Inc. (AUGX) Reports Q2 Loss, Tops Revenue Estimates
- Augmedix, Inc. (AUGX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.17 per share a year ago.
- 08/07/2023
|
Augmedix to Announce Second Quarter 2023 Financial Results and Host Investor Conference Call on August 7, 2023
- SAN FRANCISCO, July 28, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced it will report financial results for the second quarter ended June 30, 2023, on Monday, August 7, 2023, after the market closes. Company management will host a conference call that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
- 07/28/2023
|
Augmedix Prepares For Continued Growth With HCA Collaboration
- Augmedix provides ambient data collection software and services on doctor visits to increase medical care efficiencies. The firm recently announced an investment and collaboration partnership with major care provider HCA Healthcare. While the deal is still in its early stages, it could be a big boost to the company's future prospects and visibility.
- 07/19/2023
|
3 Medical Info Systems Stocks to Consider From a Prospering Industry
- Zacks Medical Info Systems industry stocks like Definitive Healthcare (DH), Clover Health Investments (CLOV) and Augmedix (AUGX) are expected to gain from new normal trends.
- 07/07/2023
|
Is Augmedix (AUGX) Stock Outpacing Its Medical Peers This Year?
- Here is how Augmedix, Inc. (AUGX) and Boston Scientific (BSX) have performed compared to their sector so far this year.
- 06/16/2023
|
Is Augmedix (AUGX) Outperforming Other Medical Stocks This Year?
- Here is how Augmedix, Inc. (AUGX) and Boston Scientific (BSX) have performed compared to their sector so far this year.
- 05/31/2023
|
Augmedix Announces Participation in Upcoming Investor Conferences
- SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced that its leadership team will attend the following investor conferences during May and June 2023.
- 05/19/2023
|
Augmedix, Inc. (AUGX) Q1 2023 Earnings Call Transcript
- Augmedix, Inc. (NASDAQ:AUGX ) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Company Participants Matt Chesler - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company LLC Brooks O'Neil - Lake Street Capital Markets Allen Klee - Maxim Group Neil Chatterji - B. Riley Securities Operator Greetings, and welcome to the Augmedix Inc. First Quarter 2023 Earnings Conference Call.
- 05/13/2023
|
Augmedix, Inc. (AUGX) Reports Q1 Loss, Tops Revenue Estimates
- Augmedix, Inc. (AUGX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.16 per share a year ago.
- 05/12/2023
|
Augmedix, Inc. (AUGX) Q4 2022 Earnings Call Transcript
- Augmedix, Inc. (NASDAQ:AUGX ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Matt Chesler - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Jared Hasson - William Blair Neil Chatterji - B. Riley Securities Allen Klee - Maxim Group Operator Greetings, welcome to Augmedix Incorporated 2022 Fourth Quarter Earnings Conference Call.
- 03/27/2023
|
Augmedix to Announce Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call on March 27, 2023
- Company also announces participation in the ViVE Conference in Nashville, TN, on March 27-28, 2023 Company also announces participation in the ViVE Conference in Nashville, TN, on March 27-28, 2023
- 03/16/2023
|
Augmedix Announces Participation in Maxim Group Healthcare IT Investor Conference on January 25
- SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that its leadership team will participate in the Maxim Group Virtual Healthcare IT Conference on Wednesday, January 25, 2023. Manny Krakaris, Chief Executive Officer, will join the “Doctors Panel” which will be webcast live at 12:30 p.m. ET. Mr. Krakaris and Paul Ginocchio, Chief Financial Officer, will also host investor meetings throughout the day.
- 01/18/2023
|
Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference
- SAN FRANCISCO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Augmedix In c. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced the Company will participate in Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York City. Augmedix's management will participate in one-on-one meetings with institutional analysts and investors throughout the day.
- 11/23/2022
|
Augmedix, Inc. (AUGX) Q3 2022 Earnings Call Transcript
- Augmedix, Inc. (NASDAQ:AUGX ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Ji-Yon Yi - Gilmartin Group LLC Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Marc Wiesenberger - B. Riley Securities Charlie Montang - Lake Street Capital Markets, LLC Allen Klee - Maxim Group Operator Greetings and welcome to Augmedix, Inc. Third Quarter 2022 Earnings Call.
- 11/14/2022
|
Augmedix to Participate at the 2022 Lytham Partners Fall Investor Conference
- SAN FRANCISCO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming Lytham Partners Fall Investor Conference.
- 09/15/2022
|
Augmedix to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
- SAN FRANCISCO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 10:50 a.m. ET.
- 08/17/2022
|
Augmedix, Inc. (AUGX) CEO Manny Krakaris on Q2 2022 Results - Earnings Call Transcript
- Augmedix, Inc. (NASDAQ:AUGX ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Caroline Paul - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Marc Wiesenberger - B. Riley Securities Allen Klee - Maxim Group Brooks O'Neil - Lake Street Capital Markets Operator Hello, and welcome to the Augmedix, Inc. Second Quarter 2022 Earnings Call.
- 08/12/2022
|
Augmedix to Report Second Quarter 2022 Financial Results on August 8, 2022
- SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the second quarter of 2022 on Monday, August 8, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
- 07/25/2022
|
Augmedix to Present at the William Blair 42nd Annual Growth Stock Conference
- SAN FRANCISCO, May 26, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming William Blair Growth Stock Conference in Chicago.
- 05/26/2022
|
Augmedix, Inc. (AUGX) CEO Manny Krakaris on Q1 2022 Results - Earnings Call Transcript
- Augmedix, Inc. (NASDAQ:AUGX ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Caroline Paul - Investor Relations Manny Krakaris - Chief Executive Officer and Board Member Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Marc Wiesenberger - B Riley FBR Brooks O'Neil - Lake Street Capital Markets Allen Klee - Maxim Group Operator Hello and welcome to the Augmedix, Inc. 2022 First Quarter Earnings Conference Call. All participants will be in listen-only mode.
- 05/09/2022
|
Augmedix to Report First Quarter 2022 Financial Results on May 9, 2022
- SAN FRANCISCO, April 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the first quarter of 2022 on Monday, May 9, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
- 04/25/2022
|
Augmedix to Participate at the 2022 Lytham Partners Spring Investor Conference
- SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming Lytham Partners Investors Conference, which will take place virtually from April 4 to April 7, 2022.
- 03/29/2022
|
Augmedix, Inc. (AUGX) CEO Manny Krakaris on Q4 2021 Results - Earnings Call Transcript
- Augmedix, Inc. (AUGX) CEO Manny Krakaris on Q4 2021 Results - Earnings Call Transcript
- 03/21/2022
|
Augmedix to Report Fourth Quarter and Full Year 2021 Financial Results on March 21, 2022
- SAN FRANCISCO, March 07, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the fourth quarter and full year 2021 on Monday, March 21, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
- 03/07/2022
|
Augmedix: A Splendid Long-Term Investing Opportunity
- Augmedix drives its revenue growth by reducing burnout of physicians who are highly productive.
- 01/21/2022
|
U.S. IPO Weekly Recap: Semiconductors And Energy Storage Lead A Spooky 14 IPO Week
- The IPO market remained active this past week as 13 IPOs raised $6.3 billion. SPAC activity kept steady with 13 blank check IPOs raising $2.1 billion.
- 10/30/2021
|
Augmedix Announces Preliminary Third Quarter 2021 Financial Results
- SAN FRANCISCO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today announced preliminary unaudited financial and operational results for the three months ended September 30, 2021.
- 10/04/2021
|
Augmedix Begins U.S. Uplisting IPO Effort
- Augmedix has filed to raise $40 million in a U.S. uplisting IPO to Nasdaq, although the final amount may differ.
- 09/23/2021
|
Augmedix Reports Second Quarter 2021 Financial Results
- SAN FRANCISCO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today reported financial results for the three months ended June 30, 2021.
- 08/10/2021
|
Augmedix Announces Partnership with Medical Advantage
- Collaboration will Bring Augmedix's Solution to Physicians Nationwide – Alleviating Burnout, Increasing Efficiency, and Improving Patient Experience Collaboration will Bring Augmedix's Solution to Physicians Nationwide – Alleviating Burnout, Increasing Efficiency, and Improving Patient Experience
- 08/10/2021
|
Augmedix to Present at the 2021 LD Micro Invitational XI
- SAN FRANCISCO, May 27, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today announced the company will be participating in the upcoming LD Micro Invitational XI investor conference.
- 05/27/2021
|
